A Multicenter, Adaptive and Randomized Blinded Controlled Trial on the Safety and Efficacy Study of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults; Adaptive COVID-19 Treatment Trial (ACTT2)

For UCSF Faculty and Staff: Please login via MyAccess to request access to update your Project.

Project contact: Annie Luetkemeyer

PI: Annie Luetkemeyer, MD

Public Summary

This study is to evaluate the safety and efficacy of different investigational therapeutics in hospitalized adults diagnosed with COVID-19. This study is designed to evaluate multiple interventions compared to placebo. The study subject and study staff will not know whether active drug or placebo was given. Initially, the trial will have 2 arms: consented subjects will receive either active product (Remdesivir) or placebo

Type of Research: Clinical trial

Topics: Clinical Presentation of Infection, Clinical Trial, Treatments, Antibody-based Treatment, Convalescent Serum, Drug Development, Drug Repurposing, Drug Treatment